MYO9B (Human) Recombinant Protein (Q01)
產品名稱: MYO9B (Human) Recombinant Protein (Q01)
英文名稱: MYO9B (Human) Recombinant Protein (Q01)
產品編號: H00004650-Q01
產品價格: 0
產品產地: 臺灣
品牌商標: Abnova
更新時間: null
使用范圍: null
亞諾法生技股份有限公司(Abnova)
- 聯系人 :
- 地址 : 臺灣臺北市內湖區洲子街 108 號 9 樓
- 郵編 : 11493
- 所在區域 : 臺灣
- 電話 : +886-920**1152 點擊查看
- 傳真 : 點擊查看
- 郵箱 : sales@abnova.com.tw
- Specification
- Product Description:
- Human MYO9B partial ORF ( AAH18108, 201 a.a. - 290 a.a.) recombinant protein with GST-tag at N-terminal.
- Sequence:
- CPDNSDPLTSMKDVLKITTCVEMLIKEQMRKYKVKMEEISQLEAAESIAFRRLSLLRQNAPWPLKLGFSSPYEGVLNKSPKTRDIQEEEL
- Theoretical MW (kDa):
- 35.64
- Preparation Method:
- in vitro wheat germ expression system
- Purification:
- Glutathione Sepharose 4 Fast Flow
- Storage Buffer:
- 50 mM Tris-HCI, 10 mM reduced Glutathione, pH=8.0 in the elution buffer.
- Storage Instruction:
- Store at -80°C. Aliquot to avoid repeated freezing and thawing.
- Quality Control Testing:
- 12.5% SDS-PAGE Stained with Coomassie Blue.

- Note:
- Best use within three months from the date of receipt of this protein.
- MSDS:
Download
- Application Image
- Enzyme-linked Immunoabsorbent Assay
- Western Blot (Recombinant protein)
- Antibody Production
- Protein Array
- Related Disease
- Angina Pectoris, Variant
- Arthritis, Rheumatoid
- Autoimmune Diseases
- Celiac Disease
- Colitis, Ulcerative
- Coronary Vasospasm
- Crohn Disease
- Crohn's disease
- Diabetes Mellitus, Type 1
- Down Syndrome
- Genetic Predisposition to Disease
- Inflammatory Bowel Diseases
- Lupus Erythematosus, Systemic
- Multiple Sclerosis
- Schizophrenia
- Schizophrenia
